Valbiotis

Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France Perigny, La Rochelle (17) and Riom (63) and a subsidiary in Quebec City (Canada)

Metabolic diseases,diabetes,prediabetes,health,prevention,nash,microbiota,microbiome,innovation,nafld,blood pressure,cholesterol,and cardiovascular diseases

Valbiotis operates in the Biotechnology research industry.

Valbiotis's revenue is 1m - 10m

Valbiotis has 51 - 200 employees.